Related Experiment Video
Updated: Mar 9, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK
Yi-Jun Shu1,2, Run-Fa Bao1,2, Lin Jiang1,2
1Department of General Surgery and Laboratory of General Surgery, Xinhua Hospital, Affiliated with Shanghai Jiao Tong University School of Medicine, No. 1665 Kongjiang Road, Shanghai 200092, China.
Abstract:
Gallbladder cancer (GBC) is a leading cause of cancer-related deaths worldwide, and its prognosis remains poor, with a 5-year survival rate of ~5%. Given the crucial role of microRNAs (miRNAs) in cancer metastasis, we aimed to analyze the expression and function of the metastasis-associated miRNA miR-29c-5p in GBC.We validated that expression of miR-29c-5p was significantly downregulated in GBC and was closely associated with lymph node metastasis, overall survival and disease-free survival in 40 GBC patients who were followed clinically. Ectopic overexpression of miR-29c-5p dramatically repressed proliferation, metastasis, and colony formation and induced apoptosis in vitro, and it suppressed tumorigenicity in vivo through the MAPK pathway. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) was identified as a critical effector target of miR-29c-5p. Enforced expression of miR-29c-5p significantly inhibited the expression of CPEB4, and restoration of CPEB4 expression reversed the inhibitory effects of miR-29c-5p on GBC cell proliferation and metastasis. Transforming growth factor-β (TGF-β) upregulated CPEB4 by downregulating miR-29c-5p, leading to MAPK pathway activation. In conclusion, the TGF-β/miR-29c-5p/CPEB4 axis has a pivotal role in the pathogenesis and poor prognosis of GBC, suggesting that miR-29c-5p is a tumor-suppressive miRNA that may serve as potential prognostic biomarker or therapeutic target for GBC.
Insights
MicroRNA miR-29c-5p is downregulated in gallbladder cancer (GBC), correlating with poor prognosis. Restoring miR-29c-5p inhibits GBC growth and metastasis by targeting CPEB4.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gallbladder cancer (GBC) presents a poor prognosis with a 5-year survival rate of approximately 5%.
- MicroRNAs (miRNAs) play a critical role in cancer metastasis, necessitating investigation into their function in GBC.
- The metastasis-associated miRNA miR-29c-5p's role in GBC requires detailed analysis.
Purpose of the Study:
- To investigate the expression and functional role of miR-29c-5p in gallbladder cancer.
- To elucidate the molecular mechanisms underlying miR-29c-5p's function in GBC progression.
- To evaluate miR-29c-5p as a potential prognostic biomarker and therapeutic target for GBC.
Main Methods:
- Expression analysis of miR-29c-5p in GBC tissues and correlation with clinical parameters.
- In vitro studies involving ectopic overexpression of miR-29c-5p to assess its effects on GBC cell proliferation, apoptosis, and metastasis.
- In vivo tumorigenicity assays and mechanistic studies involving the MAPK pathway and CPEB4 target validation.
Main Results:
- miR-29c-5p expression was significantly downregulated in GBC and associated with lymph node metastasis, overall survival, and disease-free survival.
- Overexpression of miR-29c-5p suppressed GBC cell proliferation, metastasis, and colony formation, while inducing apoptosis in vitro and inhibiting tumorigenicity in vivo via the MAPK pathway.
- Cytoplasmic polyadenylation element binding protein 4 (CPEB4) was identified as a direct target of miR-29c-5p; its restoration reversed the tumor-suppressive effects of miR-29c-5p.
Conclusions:
- The TGF-β/miR-29c-5p/CPEB4 axis is crucial in GBC pathogenesis and prognosis.
- miR-29c-5p acts as a tumor-suppressive miRNA in GBC.
- miR-29c-5p holds potential as a prognostic biomarker and therapeutic target for GBC.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Cell Specific Gene Expression

